SXI Life Sciences
7.503,52
PKT
+57,37
PKT
+0,77
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.10.25 | Roche Buy | UBS AG | |
| 13.10.25 | Novartis Neutral | UBS AG | |
| 13.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 10.10.25 | Novartis Neutral | UBS AG | |
| 08.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.10.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.10.25 | Novartis Buy | Deutsche Bank AG | |
| 29.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.09.25 | Roche Sell | Deutsche Bank AG | |
| 24.09.25 | Novartis Neutral | UBS AG | |
| 23.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.09.25 | Roche Buy | UBS AG | |
| 23.09.25 | Novartis Neutral | UBS AG | |
| 22.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.09.25 | Roche Sell | Deutsche Bank AG | |
| 18.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.09.25 | Novartis Neutral | UBS AG | |
| 12.09.25 | Novartis Sell | Goldman Sachs Group Inc. | |
| 10.09.25 | Novartis Buy | Deutsche Bank AG | |
| 09.09.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.09.25 | Novartis Neutral | UBS AG | |
| 04.09.25 | Roche Buy | UBS AG | |
| 02.09.25 | Novartis Hold | Jefferies & Company Inc. | |
| 01.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.08.25 | Novartis Neutral | UBS AG | |
| 27.08.25 | Novartis Buy | Deutsche Bank AG | |
| 22.08.25 | Novartis Neutral | UBS AG | |
| 21.08.25 | Novartis Buy | Deutsche Bank AG | |
| 12.08.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.08.25 | Novartis Outperform | Bernstein Research | |
| 01.08.25 | Roche Outperform | Bernstein Research | |
| 01.08.25 | Novartis Outperform | Bernstein Research | |
| 29.07.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 28.07.25 | Novartis Outperform | Bernstein Research | |
| 28.07.25 | Roche Buy | UBS AG | |
| 28.07.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.07.25 | Roche Kaufen | DZ BANK |